Interaction of vitamin D with membrane-based signaling pathways

Frontiers in Physiology

Volumn 5 FEB, Issue , 2014, Pages

  Larriba, María Jesús ^a   González Sancho, José Manuel ^a   Bonilla, Félix ^b   Muñoz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Cytokines; Growth factors; Membrane based signaling; Paracrine effects; VDR; Wnt

Indexed keywords

CALCITRIOL; CYTOKINE; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR; WNT PROTEIN;

CELL COMMUNICATION; CELL MEMBRANE; CHROMATIN IMMUNOPRECIPITATION; CYTOKINE RELEASE; GENOME ANALYSIS; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 84895502323     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00060     Document Type: Review

References (126)

1. Adorini, L., and Penna, G. (2008). Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4, 404-412. doi: 10.1038/ncprheum0855.
2. 3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28, 1877-1884. doi: 10.1093/carcin/bgm094.
3. 3 mediated transactivation. Exp. Cell Res. 318, 2490-2497. doi: 10.1016/j.yexcr.2012.07.020.
4. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15, 5789-5799.
5. Alvarez-Díaz, S., Larriba, M. J., López-Otín, C., and Muñoz, A. (2010). Vitamin D: proteases, protease inhibitors and cancer. Cell Cycle 9, 32-37. doi: 10.4161/cc.9.1.10266.
6. Alvarez-Díaz, S., Valle, N., Ferrer-Mayorga, G., Lombardía, L., Herrera, M., Domínguez, O., et al. (2012). MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum. Mol. Genet. 21, 2157-2165. doi: 10.1093/hmg/dds031.
7. An, B. S., Tavera-Mendoza, L. E., Dimitrov, V., Wang, X., Calderon, M. R., Wang, H. J., et al. (2010). Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol. 30, 4890-4900. doi: 10.1128/MCB.00180-10.
8. Anand, P. K., Kaul, D., and Sharma, M. (2008). Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J. Microbiol. Immunol. Infect. 41, 17-25.
9. Andl, C. D., and Rustgi, A. K. (2005). No one-way street: cross-talk between E-cadherin and receptor tyrosine kinase (RTK) signaling: a mechanism to regulate RTK activity. Cancer Biol. Ther. 4, 28-31. doi: 10.4161/cbt.4.1.1431.
10. Barbáchano, A., Ordóñez-Morán, P., García, J. M., Sánchez, A., Pereira, F., Larriba, M. J., et al. (2010). SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene 29, 4800-4813. doi: 10.1038/onc.2010.225.
11. 3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther. 6, 1433-1439. doi: 10.1158/1535-7163.MCT-06-0677.
12. 3 secretion. PLoS Biol. 4:e232. doi: 10.1371/journal.pbio.0040232.
13. Bikle, D. D. (2011). The vitamin D receptor: a tumor suppressor in skin. Discov. Med. 11, 7-17.
14. Bikle, D. D., Elalieh, H., Welsh, J., Oh, D., Cleaver, J., and Teichert, A. (2013). Protective role of vitamin D signaling in skin cancer formation. J. Steroid Biochem. Mol. Biol. 136, 271-279. doi: 10.1016/j.jsbmb.2012.09.021.
15. Brosseau, C., Pirianov, G., and Colston, K. W. (2013). Role of insulin-like growth factor binding protein-3 in 1,25-dihydroxyvitamin-D3-induced breast cancer cell apoptosis. Int. J. Cell Biol. 2013, 960378. doi: 10.1155/2013/960378.
16. 3 in a murine xenograft model for pancreatic cancer. Cancer Biol. Ther. 10, 79-88. doi: 10.4161/cbt.10.1.12165.
17. Bruns, D. E., Krishnan, A. V., Feldman, D., Gray, R. W., Christakos, S., Hirsch, G. N., et al. (1989). Epidermal growth factor increases intestinal calbindin-D9k and 1,25-dihydroxyvitamin D receptors in neonatal rats. Endocrinology 125, 478-485. doi: 10.1210/endo-125-1-478.
18. Cabrita, M. A., and Christofori, G. (2008). Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11, 53-62. doi: 10.1007/s10456-008-9089-1.
19. 3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 204, 85-89. doi: 10.1016/j.atherosclerosis.2008.08.020.
20. Carlberg, C., and Campbell, M. J. (2013). Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78, 127-136. doi: 10.1016/j.steroids.2012.10.019.
21. 3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells. Am. J. Physiol. Endocrinol. Metab. 284, E219-E227. doi: 10.1152/ajpendo.00247.2002.
22. 3 stimulates activator protein-1-dependent Caco-2 cell differentiation. J. Biol. Chem. 274, 35505-35513. doi: 10.1074/jbc.274.50.35505.
23. Chen, A., Davis, B. H., Sitrin, M. D., Brasitus, T. A., and Bissonnette, M. (2002). Transforming growth factor-β 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G864-G874. doi: 10.1152/ajpgi.00524.2001.
24. Chen, H., Reed, G., Guardia, J., Lakhan, S., Couture, O., Hays, E., et al. (2013). Vitamin D directly regulates Mdm2 gene expression in osteoblasts. Biochem. Biophys. Res. Commun. 430, 370-374. doi: 10.1016/j.bbrc.2012.11.003.
25. Chen, K., Aenlle, K. K., Curtis, K. M., Roos, B. A., and Howard, G. A. (2012). Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR. Bone 51, 69-77. doi: 10.1016/j.bone.2012.04.002.
26. Chen, K., Perez-Stable, C., D'Ippolito, G., Schiller, P. C., Roos, B. A., and Howard, G. A. (2011). Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. Bone 49, 1194-1204. doi: 10.1016/j.bone.2011.08.023.
27. Clevers, H., and Nusse, R. (2012). Wnt/β-catenin signaling and disease. Cell 149, 1192-1205. doi: 10.1016/j.cell.2012.05.012.
28. Crescioli, C., Morelli, A., Adorini, L., Ferruzzi, P., Luconi, M., Vannelli, G. B., et al. (2005). Human bladder as a novel target for vitamin D receptor ligands. J. Clin. Endocrinol. Metab. 90, 962-972. doi: 10.1210/jc.2004-1496.
29. 3 in osteoblast differentiation. Mol. Cell. Endocrinol. 338, 84-92. doi: 10.1016/j.mce.2011.03.011.
30. 3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells. Biochem. Biophys. Res. Commun. 176, 1-6. doi: 10.1016/0006-291X(91)90880-G.
31. Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., et al. (2013). A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613. doi: 10.1016/j.cell.2013.03.028.
32. 3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31, 269-275. doi: 10.1016/S8756-3282(02)00820-7.
33. 3 and its nuclear receptor. J. Mol. Biol. 349, 248-260. doi: 10.1016/j.jmb.2005.03.060.
34. Fabri, M., Stenger, S., Shin, D. M., Yuk, J. M., Liu, P. T., Realegeno, S., et al. (2011). Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 3, 104ra102. doi: 10.1126/scitranslmed.3003045.
35. 3 enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C2C12 skeletal muscle cells. J. Steroid Biochem. Mol. Biol. 133, 1-11. doi: 10.1016/j.jsbmb.2012.09.004.
36. 3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152, 2976-2986. doi: 10.1210/en.2011-0159.
37. 3 impairs NF-κB activation in human naïve B cells. Biochem. Biophys. Res. Commun. 407, 699-702. doi: 10.1016/j.bbrc.2011.03.078.
38. 3 in hypocalcemia. J. Hepatol. 26, 659-668.
39. 3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro. Spine 33, 755-765. doi: 10.1097/BRS.0b013e3181695d59.
40. Grumbles, R. M., Howell, D. S., Wenger, L., Altman, R. D., Howard, G. A., and Roos, B. A. (1996). Hepatocyte growth factor and its actions in growth plate chondrocytes. Bone 19, 255-261. doi: 10.1016/8756-3282(96)00180-9.
41. Grundmann, M., Haidar, M., Placzko, S., Niendorf, R., Darashchonak, N., Hubel, C. A., et al. (2012). Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am. J. Physiol. Cell Physiol. 303, C954-C962. doi: 10.1152/ajpcell.00030.2012.
42. 3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells. Gene 522, 142-146. doi: 10.1016/j.gene.2013.03.065.
43. 3-dependent repression of interleukin-12B. Biochim. Biophys. Acta 1813, 810-818. doi: 10.1016/j.bbamcr.2011.01.037.
44. 3 decreases DNA binding of nuclear factor-κB in human fibroblasts. FEBS Lett. 436, 329-334. doi: 10.1016/S0014-5793(98)01153-3.
45. 3. Oncogene 23, 4856-4861. doi: 10.1038/sj.onc.1207621.
46. 3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells. J. Cell. Physiol. 209, 363-369. doi: 10.1002/jcp.20741.
47. 3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood 82, 53-59.
48. 3 in the p27KIP1 gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274, 32309-32317. doi: 10.1074/jbc.274.45.32309.
49. 3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway. J. Steroid Biochem. Mol. Biol. 136, 229-232. doi: 10.1016/j.jsbmb.2012.09.024.
50. Jiménez-Lara, A. M., and Aranda, A. (1999). Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-β2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression. Endocrinology 140, 2898-2907. doi: 10.1210/endo.140.6.6770.
51. 3) inhibits androgen glucuronidation in prostate cancer cells. Mol. Cancer Ther. 7, 380-390. doi: 10.1158/1535-7163.MCT-07-0455.
52. 3. Oncogene 28, 3892-3902. doi: 10.1038/onc.2009.247.
53. 3 suppresses telomerase expression and human cancer growth through microRNA-498. J. Biol. Chem. 287, 41297-41309. doi: 10.1074/jbc.M112.407189.
54. Kostaras, E., Sflomos, G., Pedersen, N. M., Stenmark, H., Fotsis, T., and Murphy, C. (2013). SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking. Oncogene 32, 5220-5232. doi: 10.1038/onc.2012.554.
55. Kovalenko, P. L., Zhang, Z., Cui, M., Clinton, S. K., and Fleet, J. C. (2010). 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genomics 11:26. doi: 10.1186/1471-2164-11-26.
56. Krishnan, A. V., and Feldman, D. (2010). Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment. Endocr. Relat. Cancer 17, R19-R38. doi: 10.1677/ERC-09-0139.
57. Krishnan, A. V., Swami, S., Peng, L., Wang, J., Moreno, J., and Feldman, D. (2010). Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151, 32-42. doi: 10.1210/en.2009-0855.
58. Larriba, M. J., González-Sancho, J. M., Barbáchano, A., Niell, N., Ferrer-Mayorga, G., and Muñoz, A. (2013). Vitamin D is a multilevel repressor of Wnt/β-catenin signaling in cancer cells. Cancers 5, 1242-1260. doi: 10.3390/cancers5041242.
59. Li, J., Jin, D., Fu, S., Mei, G., Zhou, J., Lei, L., et al. (2013). Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Biochem. Biophys. Res. Commun. 436, 632-637. doi: 10.1016/j.bbrc.2013.04.111.
60. 3 in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J. Biol. Chem. 279, 25260-25267. doi: 10.1074/jbc.M311052200.
61. Li, Y., Spataro, B. C., Yang, J., Dai, C., and Liu, Y. (2005). 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int. 68, 1500-1510. doi: 10.1111/j.1523-1755.2005.00562.x.
62. Lin, R., Wang, T. T., Miller, W. H., and White, J. H. (2003). Inhibition of F-Box protein p45SKP2 expression and stabilization of cyclin-dependent kinase inhibitor p27KIP1 in vitamin D analog-treated cancer cells. Endocrinology 144, 749-753. doi: 10.1210/en.2002-0026.
63. Liu, P. T., Schenk, M., Walker, V. P., Dempsey, P. W., Kanchanapoomi, M., Wheelwright, M., et al. (2009). Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 4:e5810. doi: 10.1371/journal.pone.0005810.
64. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., et al. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773. doi: 10.1126/science.1123933.
65. Luderer, H. F., Gori, F., and Demay, M. B. (2011). Lymphoid enhancer-binding factor-1 (LEF1) interacts with the DNA-binding domain of the vitamin D receptor. J. Biol. Chem. 286, 18444-18451. doi: 10.1074/jbc.M110.188219.
66. 3. Nucleic Acids Res. 39, 502-512. doi: 10.1093/nar/gkq820.
67. Matilainen, J. M., Husso, T., Toropainen, S., Seuter, S., Turunen, M. P., Gynther, P., et al. (2010a). Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 1803, 1276-1286. doi: 10.1016/j.bbamcr.2010.07.009.
68. Matilainen, J. M., Räsänen, A., Gynther, P., and Väisänen, S. (2010b). The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1α,25(OH)2D3 target genes. J. Steroid Biochem. Mol. Biol. 121, 142-145. doi: 10.1016/j.jsbmb.2010.03.020.
69. 3. Nucleic Acids Res. 33, 5521-5532. doi: 10.1093/nar/gki872.
70. 3 in prostate progenitor/stem cells. Cancer Res. 71, 5276-5286. doi: 10.1158/0008-5472.CAN-10-2160.
71. Mooso, B., Madhav, A., Johnson, S., Roy, M., Moore, M. E., Moy, C., et al. (2010). Androgen Receptor regulation of Vitamin D Receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5-a calcitriol analog. Genes Cancer 1, 927-940. doi: 10.1177/1947601910385450.
72. Muthian, G., Raikwar, H. P., Rajasingh, J., and Bright, J. J. (2006). 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis. J. Neurosci. Res. 83, 1299-1309. doi: 10.1002/jnr.20826.
73. 3 via the NF-κB pathway. FASEB J. 26, 4400-4407. doi: 10.1096/fj.12-210880.
74. Ng, K. Y., Ma, M. T., Leung, K. K., and Leung, P. S. (2010). Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Rev. 7, 53-63. doi: 10.1007/s12015-010-9146-1.
75. 3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Mol. Cell. Endocrinol. 183, 141-149. doi: 10.1016/S0303-7207(01)00598-6.
76. Okuda, N., Takeda, S., Shinomiya, K., Muneta, T., Itoh, S., Noda, M., et al. (2007). ED-71, a novel vitamin D analog, promotes bone formation and angiogenesis and inhibits bone resorption after bone marrow ablation. Bone 40, 281-292. doi: 10.1016/j.bone.2006.08.017.
77. Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., et al. (2001). Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369-387. doi: 10.1083/jcb.200102028.
78. 3 in human colon cancer cells. Cancer Res. 63, 7799-7806.
79. 3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J. Biol. Chem. 274, 8437-8444. doi: 10.1074/jbc.274.13.8437.
80. Parikh, G., Varadinova, M., Suwandhi, P., Araki, T., Rosenwaks, Z., Poretsky, L., et al. (2010). Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm. Metab. Res. 42, 754-757. doi: 10.1055/s-0030-1262837.
81. Pickup, M., Novitskiy, S., and Moses, H. L. (2013). The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer 13, 788-799. doi: 10.1038/nrc3500.
82. Qadan, L. R., Perez-Stable, C. M., Schwall, R. H., Burnstein, K. L., Ostenson, R. C., Howard, G. A., et al. (2000). Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines. Endocrinology 141, 2567-2573. doi: 10.1210/endo.141.7.7546.
83. Reichrath, S., and Reichrath, J. (2012). No evidence for induction of key components of the Notch signaling pathway (Notch-1, Jagged-1) by treatment with UV-B, 1,25(OH)2D3, and/or epigenetic drugs (TSA, 5-Aza) in human keratinocytes in vitro. Dermatoendocrinology 4, 44-52. doi: 10.4161/derm.19027.
84. 3 on the expressions of vascular endothelial growth factor and transforming growth factor-β1 in the retinas of rats with diabetes. Diabetes Res. Clin. Pract. 98, 474-480. doi: 10.1016/j.diabres.2012.09.028.
85. Rodilla, V., Villanueva, A., Obrador-Hevia, A., Robert-Moreno, A., Fernandez-Majada, V., Grilli, A., et al. (2009). Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 106, 6315-6320. doi: 10.1073/pnas.0813221106.
86. 3 response of the interleukin 8 gene cluster in human monocyte-and macrophage-like cells. PLoS ONE 8:e78170. doi: 10.1371/journal.pone.0078170.
87. Salehi-Tabar, R., Nguyen-Yamamoto, L., Tavera-Mendoza, L. E., Quail, T., Dimitrov, V., An, B. S., et al. (2012). Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc. Natl. Acad. Sci. U.S.A. 109, 18827-18832. doi: 10.1073/pnas.1210037109.
88. Schauber, J., Dorschner, R. A., Coda, A. B., Buchau, A. S., Liu, P. T., Kiken, D., et al. (2007). Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803-811. doi: 10.1172/JCI30142.
89. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res. 23, 213-229.
90. Schnabel, M., Fichtel, I., Gotzen, L., and Schlegel, J. (2002). Differential expression of Notch genes in human osteoblastic cells. Int. J. Mol. Med. 9, 229-232.
91. Seoane, S., and Pérez-Fernández, R. (2006). The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor. Mol. Endocrinol. 20, 735-748. doi: 10.1210/me.2005-0253.
92. Sertznig, P., Dunlop, T., Seifert, M., Tilgen, W., and Reichrath, J. (2009a). Cross-talk between vitamin D receptor (VDR)-and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Anticancer Res. 29, 3647-3658.
93. Sertznig, P., Seifert, M., Tilgen, W., and Reichrath, J. (2009b). Activation of vitamin D receptor (VDR)-and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)2D3 in melanoma cell lines and other skin-derived cell lines. Dermatoendocrinology 1, 232-238. doi: 10.4161/derm.1.4.9629.
94. Shah, S., Islam, M. N., Dakshanamurthy, S., Rizvi, I., Rao, M., Herrell, R., et al. (2006). The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol. Cell 21, 799-809. doi: 10.1016/j.molcel.2006.01.037.
95. Shalhoub, V., Shatzen, E. M., Ward, S. C., Young, J. I., Boedigheimer, M., Twehues, L., et al. (2010). Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol. J. Cell. Biochem. 111, 911-921. doi: 10.1002/jcb.22779
96. Shen, Q., and Christakos, S. (2005). The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J. Biol. Chem. 280, 40589-40598. doi: 10.1074/jbc.M504166200.
97. 3. Steroids 72, 930-938. doi: 10.1016/j.steroids.2007.08.003.
98. 3 action in osteoblast-like cells. Bone Miner. 26, 27-42. doi: 10.1016/S0169-6009(08)80160-2.
99. 3 in mouse long bones: interaction with the bone-derived growth factors TGF-β and IGF-I. J. Bone Miner. Res. 13, 36-43. doi: 10.1359/jbmr.1998.13.1.36.
100. 3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 137, 2001-2011. doi: 10.1210/endo.137.5.8612541.
101. 3 response by cancer-associated mutant p53. Cancer Cell 17, 273-285. doi: 10.1016/j.ccr.2009.11.025.
102. Sun, J., Kong, J., Duan, Y., Szeto, F. L., Liao, A., Madara, J. L., et al. (2006). Increased NF-κB activity in fibroblasts lacking the vitamin D receptor. Am. J. Physiol. Endocrinol. Metab. 291, E315-E322. doi: 10.1152/ajpendo.00590.2005.
103. Swami, S., Krishnan, A. V., Peng, L., Lundqvist, J., and Feldman, D. (2013). Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements. Endocr. Relat. Cancer 20, 565-577. doi: 10.1530/ERC-12-0281.
104. Tang, J. Y., Xiao, T. Z., Oda, Y., Chang, K. S., Shpall, E., Wu, A., et al. (2011). Vitamin D3 inhibits hedgehog signaling and proliferation in murine basal cell carcinomas. Cancer Prev. Res. 4, 744-751. doi: 10.1158/1940-6207.CAPR-10-0285.
105. Tang, W. B., Ling, G. H., Sun, L., and Liu, F. Y. (2010). Smad anchor for receptor activation (SARA) in TGF-β signaling. Front. Biosci. 2, 857-860. doi: 10.2741/E147.
106. Tavera-Mendoza, L., Wang, T. T., Lallemant, B., Zhang, R., Nagai, Y., Bourdeau, V., et al. (2006). Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 7, 180-185. doi: 10.1038/sj.embor.7400594.
107. Thorne, J. L., Maguire, O., Doig, C. L., Battaglia, S., Fehr, L., Sucheston, L. E., et al. (2011). Epigenetic control of a VDR-governed feed-forward loop that regulates p21waf1/cip1 expression and function in non-malignant prostate cells. Nucleic Acids Res. 39, 2045-2056. doi: 10.1093/nar/gkq875.
108. Ting, H. J., Bao, B. Y., Hsu, C. L., and Lee, Y. F. (2005). Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocrine 26, 1-9. doi: 10.1385/ENDO:26:1:001.
109. Tong, W.-M., Hofer, H., Ellinger, A., Peterlik, M., and Cross, H. S. (1999). Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Oncol. Res. 11, 77-84.
110. 3 is mediated by mutual modulation of receptor expression. Eur. J. Cancer 34, 2119-2125. doi: 10.1016/S0959-8049(98)00267-6.
111. 3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol. 400, 284-294. doi: 10.1016/j.jmb.2010.05.031.
112. 3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol. Cell. Biol. 19, 4191-4199.
113. Uhmann, A., Niemann, H., Lammering, B., Henkel, C., Hess, I., Nitzki, F., et al. (2011). Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Mol. Cancer Ther. 10, 2179-2188. doi: 10.1158/1535-7163.MCT-11-0422.
114. Uhmann, A., Niemann, H., Lammering, B., Henkel, C., Hess, I., Rosenberger, A., et al. (2012). Calcitriol inhibits Hedgehog signaling and induces vitamin D receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma. Sarcoma 2012, 357040. doi: 10.1155/2012/357040.
115. 3 analogue EB1089. Eur. J. Cancer 32A, 842-848. doi: 10.1016/0959-8049(95)00647-8.
116. 3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer 10, 58. doi: 10.1186/1476-4598-10-58.
117. 3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization. Gene 512, 438-443. doi: 10.1016/j.gene.2012.07.051.
118. 3 being dominant over interferon-β in stimulating mineralization. J. Cell. Physiol. 227, 3258-3266. doi: 10.1002/jcp.24020.
119. 3 stimulates activin A production to fine-tune osteoblast-induced mineralization. J. Cell. Physiol. 228, 2167-2174. doi: 10.1002/jcp.24388.
120. Wu, F. S., Zheng, S. S., Wu, L. J., Teng, L. S., Ma, Z. M., Zhao, W. H., et al. (2007). Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down-modulating c-met and ERK expressions. Liver Int. 27, 700-707. doi: 10.1111/j.1478-3231.2007.01487.x.
121. Yanagi, Y., Suzawa, M., Kawabata, M., Miyazono, K., Yanagisawa, J., and Kato, S. (1999). Positive and negative modulation of vitamin D receptor function by transforming growth factor-β signaling through Smad proteins. J. Biol. Chem. 274, 12971-12974.
122. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., et al. (1999). Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321.
123. 3. Proc. Natl. Acad. Sci. U.S.A. 92, 10990-10994.
124. 3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282, 29821-29830. doi: 10.1074/jbc.M705495200.
125. Zhang, G. Y., Cheng, T., Luan, Q., Liao, T., Nie, C. L., Zheng, X., et al. (2011). Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br. J. Dermatol. 164, 729-737. doi: 10.1111/j.1365-2133.2010.10130.x.
126. 3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140, 1205-1212. doi: 10.1210/endo.140.3.6561.